Source: Medical Device News Magazine

BioStable Science & Engineering: HAART 200 Aortic Annuloplasty Device: 1st European Commercialization Implantation Reported

First commercial implantations of the HAART 200 Device for Bicuspid Aortic Valve repair performed by Professor Marek Jasinski at the Wroclaw Medical University. The post HAART 200 Aortic Annuloplasty Device: 1st European Commercialization Implantation Reported appeared first on Medical Device News Magazine.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
John Wheeler's photo - President & CEO of BioStable Science & Engineering

President & CEO

John Wheeler

CEO Approval Rating

90/100

Read more